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Management of 
aortic stenosis in pregnancy
AORTIC STENOSIS 
IN PREGNANCY
The most important part of the assessment, as in other fields 
of medicine, is the history. The presence of symptoms, espe-
cially dyspnea, determines the prognosis. Clinical signs of 
severe AS are similar for pregnant patients when compared 
with non-pregnant patients. 
Echocardiographic assessment of AS (Table 1) should include 
peak and mean gradients, effective aortic valve area (indexed 
for body surface area) and dimensionless velocity index 
(DVI).(7) It should be remembered that during pregnancy the 
stroke volume and left ventricular outflow tract velocity time 
integral (LVOT VTI) increase, which would increase the 
gradient across the aortic valve without change to the aortic 
valve area.(8) It is important to align the jet of AS correctly. 
An eccentric jet is common in AS secondary to bicuspid valves 
and thus the freestanding probe should always be used to 
eliminate the underestimation of the gradient.(4) The most com-
mon error that causes overestimation of aortic valve severity 
is incorrect measurement of the left ventricular outflow tract 
(LVOT) diameter. An LVOT diameter of less than 17mm 
should always raise concern as to an incorrect measure-
ment. The DVI is very useful as a “check and balance” for 
this common mistake. A DVI of less than 0.25 is in keeping 
with severe AS. Other helpful parameters in the assessment of 
AS is the jet shape and time to peak (TTP). A more parabolic 
shape with a late peak (TTP more than 100ms) indicates 
severe AS.(1,3)
ABSTRACT
Aortic stenosis in pregnancy is most commonly related 
to congenital or bicuspid aortic stenosis, which is asso-
ciated with an aortopathy and ascending aortic dilata-
tion. The management of AS in pregnancy is based on 
a few key principles. First and foremost the accurate 
assessment of the patient’s symptoms and confi rma-
tion, via echocardiography, of the degree of AS is of the 
utmost importance. Exercise testing is a very handy 
adjunct to quantify symptoms. Based on these fi ndings, 
an informed process of discussion between the patient 
and a multidisciplinary team will lead to the correct 
management. As a general rule, patients who are truly 
asymptomatic with normal left ventricular systolic 
function and normal aortic root are able to tolerate 
pregnancy with a low maternal and fetal risk.  
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The correct management of aortic stenosis (AS) hinges on 
thorough clinical assessment and meticulous incorporation of 
all parameters of the echocardiographic assessment. In the 
pregnant patient, or patients planning pregnancy, this is even 
more important. The assessment of AS can be very simple, but 
more often than not it is extremely difficult with many caveats 
and it has aptly been described as an art.(1) Managing AS in 
pregnancy is even more of an art, filled with many difficulties 
but also great rewards if correct assessments are made and 
correct decisions are taken. The decisions should be the result 
of a multidisciplinary team effort with the patient, cardiologist, 
obstetrician, pediatrician and anesthetist all playing their part 
towards the optimal care of mother and baby.
AS impacting on pregnancy is mostly congenital in origin, 
with bicuspid aortic valve disease being the most common 
cause.(2-5) Rheumatic AS is another important cause, especially 
in developing countries.(6) The majority of rheumatic AS is 
accompanied by rheumatic mitral valve involvement, although 
rare cases of isolated rheumatic AS have been seen. Supra- and 
infra-valvular stenoses are less common and their assessment 
and treatment will not be discussed in this review.(2)
ASSESSMENT OF SEVERITY
Assessment of AS in pregnancy follows the same principles as 
assessment in patients that are not pregnant. Three fundamental 
questions must be answered:
1.  Is the patient symptomatic?
2.  Is the aortic valve stenosis severe?
3.  Can we attribute the symptoms to the aortic valve disease?
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Two other very important parts of the echocardiographic 
assessment is left ventricular systolic (and diastolic) function 
and aortic root size. It is important to accurately quantify 
systolic function as impairment significantly increases the risk 
of adverse events in pregnancy. Normal diastolic function with 
a non-dilated left atrium is typical of the asymptomatic patient. 
As a bicuspid aortic valve is the most common cause of AS in 
the pregnant population, the risk of an associated aortopathy, 
which in turn increases the risk of aortic dilatation and dissec-
tion, deserves careful attention. The pathology and histology is 
similar to Marfan syndrome and leads to fusiform dilatation of 
the ascending aorta. The degree of dilation does not correlate 
with the severity of the AS, some patients with only mild AS 
have severe aortic root dilatation.(5) The theory of post stenotic 
dilatation has largely been abandoned. An aortic root meas-
urement at any level of more than 50mm is associated with a 
marked increase in the risk of aortic dissection and surgery 
prior to conception should be advocated.(2,3)
Exercise testing of patients with severe AS prior or during 
pregnancy is an important part of the evaluation and manage-
ment of patients.(2,3)
NATURAL HISTORY OF AS IN PREGNANCY
Cardiac output increases by 25-50% by the 24th week of 
gestation. This is accompanied by a similar increase in blood 
volume.(4,8) Patients with severe AS that become symptomatic 
are unable to meet the haemodynamic and metabolic demand 
of pregnancy due to the fixed left ventricular outflow tract 
obstruction.(4) In South Africa we frequently deal with mitral 
stenosis (MS) during pregnancy and are well aware of the dire 
haemodynamic consequences during pregnancy. The generally 
more favorable view of AS in pregnancy compared to MS is 
due to the more straightforward haemodynamic challenge. 
Increased cardiac output increases the trans aortic gradient but 
the rise in pressure is borne by the hypertrophied left ventricle 
in systole and not the pulmonary veins in diastole (as is the case 
with MS). The increase in extracellular fluid and plasma volume 
may increase the diastolic volume with only minimal increase in 
LV filling pressure. Patients with severe AS are mostly preload 
sensitive and pregnancy is unlikely to cause a catastrophic 
decrease in filling pressure. The effect of reducing filling time is 
much less pronounced than in MS, so that the inevitable 
increase in heart rate during pregnancy presents less of a 
problem. Thus the ability to predict the haemodynamic impact 
of pregnancy on AS is simpler than in patients with MS and 
offers fewer surprises during pregnancy.(5) Most patients with 
mild and moderate AS with normal left ventricular ejection 
fraction (LVEF) and aortic root diameter have a favorable 
outcome with pregnancy.(3,5,8) Symptoms and exercise testing 
predict the maternal risk with severe AS. Patients who are 
asymptomatic and remain asymptomatic during exercise stress 
testing should be able to sustain pregnancy with limited 
maternal risk.(3) Previous studies of severe AS in pregnancy site 
a 17% maternal mortality rate, but a recent report by Silverside 
and colleagues report no maternal deaths with congenital AS 
of whom 59% of patients had severe AS.(6,8) Cardiac com-
plications (heart failure and arrhythmias) with severe AS were 
reported at a rate of ±10%, while cardiac complications in 
mild/moderate AS are rare.(6) Severe AS is also associated 
with a higher incidence of preterm labor, intrauterine growth 
retardation and lower birth weight.(1,8) The onset of symp-
toms in patients during pregnancy usually manifests around 
20 weeks gestation when the haemodynamic load on the 
heart significantly increases. Onset of symptoms related to AS 
before this stage is a poor prognostic sign. Obstetric compli-
cations specific to AS have not been specifically investigated, 
but hypertension related disorders and preterm labor is 
more common in patients with moderate/severe AS.(3) When 
patients remain asymptomatic during pregnancy, the final 
haemodynamic challenge occur during the time of delivery and 
immediate postoperative period.
PRE PREGNANCY EVALUATION AND 
MANAGEMENT
All patients should receive detailed counseling regarding poten-
tial risks and treatments before and during pregnancy.(3,8,9) It is 
especially true for patients with a bicuspid aortic valve as fetal 
congenital heart disease occurs in ±4% of women with con-
genital AS. Fetal ultrasound is suggested when the mother has 
a bicuspid aortic valve. Pregnancy itself and the aortopathy 
associated carry a well-documented risk of aortic dissection. 
The absolute risk of dissection is difficult to estimate, but 
currently a diameter of less than 45mm is considered safe to 
proceed with pregnancy (risk of dissection equal to the general 
population).(5)
Patients with severe AS who are asymptomatic should tolerate 
pregnancy provided:
 ■ Normal LV systolic function. 
 ■ Aortic root diameter less than 45mm.
 ■ Complete exercise testing without symptoms or fall in 
blood pressure.
 ■ Severe LVH excluded (<16mm posterior wall thickness).(3)
TABLE 1: Echocardiographic parameters of severe AS.(7)
Mean gradient* >40mmHg
Peak velocity* 4m/s
Aortic valve area <1cm2
Aortic valve area index for BSA <0.6cm2/m2
Dimensionless Velocity index (DVI) 0.25
Time to peak >100ms
*Patients with normal cardiac output/transvalvular flow. BSA = body surface index.
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However, although the maternal mortality is low (<1%) the risk 
of maternal cardiac and fetal complications is higher than in 
patients with mild/moderate AS.(6) Patients with moderate or 
mild AS tolerate pregnancy well. It is important to remember 
mild or moderate AS should not cause symptoms in non-
pregnant patients. If symptoms are present in patients with mild 
or moderate stenosis critical review of the clinical and echo-
cardiographic findings is mandatory.
Patients with severe AS who are symptomatic, have impaired 
left ventricular (LV) systolic function or an aortic root diam-
eter of more than 50mm should be considered for surgery 
prior to conception.(3,5) The group of patients with an aortic 
diameter between 45mm and 50mm pose a difficult challenge 
and should be individualised. It is important to note that 
dilatation of the aorta to less than 45mm is common and does 
not carry additional risk. Aortic dissection in patients with 
bicuspid aortic valve disease and aortic root less than 50mm 
remains rare and a balanced opinion should be given to patients 
during pre pregnancy counseling.
MANAGEMENT OF SEVERE AS DURING 
PREGNANCY
Unfortunately we as clinicians are often confronted with 
patients already pregnant at time of first consultation. During 
the first trimester the same principles as the pre pregnancy 
evaluation apply. Patients who are asymptomatic and can com-
plete an exercise test should be advised to continue pregnancy. 
Patients who are symptomatic or become symptomatic during 
the exercise test, have impaired LV systolic function or dilated 
aortic root should be counseled about risks and termination 
advised.(3,5) It is important to remember that patients often 
feel tired during pregnancy, especially during the first trimester, 
thus objective evidence of dyspnea should be sought before 
making any recommendation. Patients who remain asymp-
tomatic during the second and third trimester should be 
carefully followed and vaginal delivery with assisted second 
stage is advised. 
Patients who become symptomatic during the second and third 
trimester pose a difficult challenge. A trial of medical therapy in 
the form of bed rest and diuretics is usually the initial step. 
If medical therapy fails, the options are: 
 ■ Termination of pregnancy if not viable.
 ■ Delivery of fetus.
 ■ Balloon valvotomy or valve replacement.
It is important to involve a multidisciplinary team including 
an obstetrician, neonatologist, anesthetist and cardiothoracic 
surgeon to advise on the most appropriate therapy. Patients 
with a viable fetus should generally be delivered before an 
intervention on the valve is attempted. In patients with a non-
viable fetus the decision lies between termination of pregnancy 
or intervention on the aortic valve. If the valve is suitable for 
balloon dilatation, it is generally favored to surgery with a non-
viable fetus. A mobile valve with minimal calcium and aortic 
regurgitation has a low risk for complications during balloon 
dilatation with favorable short-term outcome.(5,8) It must be 
noted that balloon valvotomy can induce aortic regurgitation 
and recurrent stenosis is common within 6-12 months.(5) Radi-
ation exposure should be limited and appropriate shielding 
used. Patients with severe AS not suitable for balloon dilata-
tion should be considered for surgery, although the risk of 
spontaneous termination and fetal sequelae is higher than with 
balloon dilatation. Maternal mortality during cardiopulmonary 
bypass is similar to that of a non pregnant patient, but fetal 
mortality as high as 30% has been reported.(6) Fetal morbidity 
also remains high with late neurological impairment at 3-6% 
the most commonly encountered problem. Cardiac surgery is 
thus only recommended if medical or interventional therapy 
fails and the mother’s life is threatened.(3) If surgery is to be 
performed, the period between the 13th and 28th week is 
preferred. The reason for this is the high risk of fetal mal-
formations with surgery in the first trimester and an increase 
in maternal complications during the third trimester. Improve-
ment in neonatal care has lead to an improved survival of 
premature infants and thus delivery via caesarian section before 
aortic valve surgery should be considered from 26 weeks 
onwards. Corticosteroids should be administered 24 hours 
before surgery to augment fetal lung maturity if possible.
MODE OF DELIVERY
For patients with asymptomatic severe AS that have pro-
gressed through pregnancy the preferred mode of delivery is 
vaginal. Some groups favor vaginal delivery with early epidural 
and good pain management to attenuate the increase in 
catecholamine release and cardiac output during labour.(6) 
Vaginal delivery is associated with less blood loss, infection, 
venous thrombosis and thromboembolic complications com-
pared to caesarian section. It is important that every patient 
has an individualised delivery plan. There is no consensus on 
absolute contraindications to vaginal delivery. The decision to 
recommend a caesarian section should be based on obstetric 
indications and the anticipated cardiopulmonary tolerance of 
the patient during delivery.(2-5) Patients with severe heart failure 
or dilated aortic root (>50mm) should be delivered via 
caesarean section.(3) Some centers advocate routine caesarian 
section for patients with severe AS although that is not cur-
rently supported by the guidelines.(3) Several publications have 
noted a high rate of caesarian section in these patients with 
favorable outcomes.(4) Currently we would recommend discus-
sion by a multi disciplinary team, before decisions on the mode 
of delivery is taken. Careful monitoring during delivery and in 
the post partum period is of the utmost importance as auto-
transfusion leads to an increase in circulating volume. This 
frequently leads to symptoms in patients with obstructive 
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lesions such as AS. Endocarditis prophylaxis is not indicated 
during vaginal or caesarian delivery. Anesthetic management 
of these patients must be individualised based on the antici-
pated effect of selected anesthetic technique on the cardiac 
performance.(10)
POST DELIVERY CARE
The bulk of the haemodynamic load on the heart occurs during 
contractions and the hours after delivery. Patients with severe 
AS should be carefully monitored for the first 24-48 hours after 
delivery in a high care unit, with invasive monitoring and imme-
diate correction of haemodynamic problems. Important goals 
of management of this period include maintaining adequate 
systemic vascular resistance and normal heart rate. Adequate 
pain relief is of the utmost importance.(4) Patients who remain 
asymptomatic during this period can be treated according to 
standard protocols. Patients who become symptomatic should 
be treated with diuretics and carefully monitored until the effect 
of auto-transfusion has subsided.
CONCLUSION
The management of AS in pregnancy is based on a few key 
principles. First and foremost the accurate assessment of 
the patient’s symptoms and confirmation, via echocardio-
graphy, of the degree of AS is of utmost importance. Exercise 
testing is a very handy adjunct to quantify symptoms. Based 
on these findings, an informed process of discussion with the 
patient, obstetrician, anesthetist, cardiothoracic surgeon and 
neonatologist will ensure good decision making and accurate 
recommendations. As a general rule, patients who are truly 
asymptomatic with normal left ventricular systolic function and 
normal aortic root are able to tolerate pregnancy with a low 
maternal and fetal risk.
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